Livia A Veress

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. pmc Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction
    Livia A Veress
    Department of Pediatrics, University of Colorado Health Sciences Center, Denver, CO, USA
    Am J Respir Cell Mol Biol 48:439-47. 2013
  2. pmc Airway obstruction due to bronchial vascular injury after sulfur mustard analog inhalation
    Livia A Veress
    Department of Pediatrics, University of Colorado Health Sciences Center, Denver, USA
    Am J Respir Crit Care Med 182:1352-61. 2010
  3. pmc Airway tissue factor-dependent coagulation activity in response to sulfur mustard analog 2-chloroethyl ethyl sulfide
    Raymond C Rancourt
    Department of Pediatrics, National Jewish Health, Denver, Colorado 80206, USA
    Am J Physiol Lung Cell Mol Physiol 302:L82-92. 2012
  4. pmc Tissue factor pathway inhibitor prevents airway obstruction, respiratory failure and death due to sulfur mustard analog inhalation
    Raymond C Rancourt
    Department of Pediatrics, University of Colorado, Denver, CO, USA Electronic address
    Toxicol Appl Pharmacol 272:86-95. 2013
  5. pmc Treatment with the catalytic metalloporphyrin AEOL 10150 reduces inflammation and oxidative stress due to inhalation of the sulfur mustard analog 2-chloroethyl ethyl sulfide
    Heidi C O'Neill
    Department of Pharmaceutical Sciences, University of Colorado at Denver Health Sciences Center, Denver, CO 80217, USA
    Free Radic Biol Med 48:1188-96. 2010

Collaborators

  • Raymond C Rancourt
  • Carl W White
  • Tara B Hendry-Hofer
  • Heidi C O'Neill
  • Aftab Ahmad
  • Jacqueline S Rioux
  • Rhonda B Garlick
  • Xiaoling Guo
  • Tara N Jones
  • Joan E Loader
  • Brian J Day
  • Elysia Min
  • Jie Huang

Detail Information

Publications5

  1. pmc Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction
    Livia A Veress
    Department of Pediatrics, University of Colorado Health Sciences Center, Denver, CO, USA
    Am J Respir Cell Mol Biol 48:439-47. 2013
    ..Most importantly, mortality, which was associated with hypoxemia and clinical respiratory distress, was eliminated...
  2. pmc Airway obstruction due to bronchial vascular injury after sulfur mustard analog inhalation
    Livia A Veress
    Department of Pediatrics, University of Colorado Health Sciences Center, Denver, USA
    Am J Respir Crit Care Med 182:1352-61. 2010
    ..This process with SM is poorly understood because animal models are unavailable...
  3. pmc Airway tissue factor-dependent coagulation activity in response to sulfur mustard analog 2-chloroethyl ethyl sulfide
    Raymond C Rancourt
    Department of Pediatrics, National Jewish Health, Denver, Colorado 80206, USA
    Am J Physiol Lung Cell Mol Physiol 302:L82-92. 2012
    ..These findings indicate that TF pathway inhibition could be an effective strategy to prevent airway obstruction after SM or CEES inhalation...
  4. pmc Tissue factor pathway inhibitor prevents airway obstruction, respiratory failure and death due to sulfur mustard analog inhalation
    Raymond C Rancourt
    Department of Pediatrics, University of Colorado, Denver, CO, USA Electronic address
    Toxicol Appl Pharmacol 272:86-95. 2013
    ..The objective of this study was to determine whether recombinant tissue factor pathway inhibitor (TFPI) could inhibit this pathogenic sequence...
  5. pmc Treatment with the catalytic metalloporphyrin AEOL 10150 reduces inflammation and oxidative stress due to inhalation of the sulfur mustard analog 2-chloroethyl ethyl sulfide
    Heidi C O'Neill
    Department of Pharmaceutical Sciences, University of Colorado at Denver Health Sciences Center, Denver, CO 80217, USA
    Free Radic Biol Med 48:1188-96. 2010
    ..Further investigation utilizing catalytic antioxidants as treatment for SM inhalation injury is warranted...